FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, specifically infectious diseases, and can be used to treat HIV/AIDS. Method and use according to the invention comprise administering an effective amount of a bisphosphonate in a composition having a particle diameter in the range of 0.03-1.0 microns.
EFFECT: use of inventions improves the clinical results of treatment by effectively capturing particles of said diameter by macrophages and monocytes.
44 cl, 10 dwg, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DOUBLE VECTOR FOR SUPPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS | 2010 |
|
RU2562868C2 |
| TREATMENT AND FUNCTIONAL CURE OF HIV-INFECTION WITH MONOCLONAL ANTIBODIES TO CD4 MEDIATING COMPETITIVE INHIBITION OF HIV ENTRY | 2014 |
|
RU2762315C2 |
| QUINOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING VIRAL INFECTION | 2016 |
|
RU2723016C2 |
| DRUG FOR HIV-INFECTION TREATMENT | 2007 |
|
RU2379049C2 |
| NOVEL QUINOLINE DERIVATIVE FOR USE IN TREATING AND PREVENTING VIRAL INFECTIONS | 2016 |
|
RU2723013C2 |
| INGENOL DERIVATIVES FOR REACTIVATION OF LATENT HIV VIRUS | 2013 |
|
RU2609512C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HIV DISEASE IN HUMANS | 2012 |
|
RU2609769C2 |
| CCR5 EXPRESSION SUPRESSION COMPOSITIONS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2353357C2 |
| USING LYSOZYME DIMER AS DRUG AND COMPOSITIONS CONTAINING THEREOF | 1993 |
|
RU2145875C1 |
| ANTIBODY AND CHEMOKINE CONSTRUCTS AND USES THEREOF IN IMMUNOLOGICAL DISORDERS | 2001 |
|
RU2252786C2 |
